ArticleScientific reports2025
MobileDANet integrating transfer learning and dynamic attention for classifying multi target histopathology images with explainable AI.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A lightweight ResNet50V2-ECA model for renal cell carcinoma grading: efficiency, calibration, and state-of-the-art performance.Scientific reports · 2026Article
- Applications, image analysis, and interpretation of computer vision in medical imaging.Frontiers in radiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer is a life-threatening disease that affects several human lives all over the world. The classification of cancer severities utilizing histopathological images is vital for effective and timely diagnosis. This always creates a demandable requirement for promising and automated computer-aided diagnosis (CAD) frameworks in clinical analysis. In this direction, the study introduces a deep learning (DL) framework aimed at classifying renal cell carcinoma (RCC) into five distinct grades, and the work is also extended to include histopathology images of breast and colon cancer. The proposed architecture, MobileDANet, integrates a MobileNetV2 backbone with a dynamic attention (DA) block (multi-head attention + MLP) to capture both long and long-range dependencies efficiently and employs Grad-CAM for interpretability. On RCC (KMC dataset) data, MobileDANet attains 90.71% accuracy (F1 score as 90.94%); on BreakHis, it achieves a recognition rate of 88.16%; and on CRCH, it reaches a weighted F1-score of 99.08%, outperforming recent baselines. In future work, the framework will be extended to larger multi-institutional datasets, pursue model compression with automated hyperparameter optimization, and explore integration with clinical-decision support systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.